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Introduction
The prevalence of breast cancer has been reported to be 
more than 23% in 40 to 55 years old women around the 
world.1,2 Due to medical progresses; many people are 
living with cancer nowadays compared to before. Despite 
the progressive treatments, expectations and needs of 
patients had often been attend.3 Emotional health is one 
of the important aspects of health that is of psychologists’ 
interest. Breast cancer can develop a lot of deep emotions 
such as depression, anxiety and emotions accompanying 
anxiety and depression such as feelings of worthlessness 
or hopelessness. Also, reactions such as denial, anger and 
feeling of guilt can be seen and they affect patients’ general 
health negatively. Some patients, at the end of medical 
therapy, find out that the cancer has brought about 
negative stable psychological consequences for them.4,5
One of the treatments that their impact is clearly 
shown in this symptom, is metacognition therapy6 not 
only this treatment method pay attention on changing 
and acceptance but also this method has short sessions.7,8 
Metacognition includes understanding of inner states 
and coping strategies9 also discussing about positive and 
negative beliefs are emphasized.10
According to some studies, the other treatment 
that has been shown to have clinical benefits in the 
treatment of anxiety and depression is mindfulness-
based cognitive therapy (MBCT) is presented by Kabat-
Zinn.11,12 Mindfulness is described as the use of a unique 
and targeted approach in the present moment without 
making any judgments.13-15 Reducing anxiety, promoting 
quality of life, increasing self-acceptance are goals in this 
method.16-18
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Abstract
Background: The present study aimed to compare the effectiveness the metacognition treatment 
(MCT) and mindfulness-based cognitive therapy (MBCT) on anxiety, depression, and stress in the 
females with breast cancer. 
Methods: The planning of this study is through a quasi-experimental method of pretest and 
posttest type with control group. The target society of the research included every cancer patient 
who admitted to Tehran hospitals for breast cancer. Through assigned randomly, 12 patients were 
selected for the MCT group and 12 patients for the MBCT group, and the other were assigned 
control group. The data collection tools included depression, anxiety and stress scale - 21 items 
(DASS-21) questionnaire. For statistical analysis, descriptive tests and repeated measures analysis of 
variance were performed. 
Results: Data analysis with repeated multivariate measurements illustrated that there is a significant 
difference in the rate of depression, anxiety and stress, in three groups. 
Conclusion: According to our results, MBCT was more effective compared to metacognitive therapy.
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According to some studies, MBCT has been shown to 
have clinical benefits in cancer treatment.19-21 Also studies 
about metacognition has been illustrated about impact of 
this treatment in depression patients,22, 23 post-traumatic 
stress disorder24 and anxiety disorders.25
Therefore, in order to address this research gap and the 
need to improve and reduce anxiety, depression and stress 
in these patients, it is necessary to conduct such a study. 
Consequently, the theoretical and research principles and 
information on the impact of metacognition treatment 
(MCT) and MBSR in females with breast cancer are 
sparse.
Materials and Methods
The planning of this study is through a quasi-experimental 
method of pre-test and post-test type with control group. 
The target society of the research included all women who 
referred to the Division of Oncology and Radiotherapy of 
Imam Hossein hospital during March 2016 to May 2017. 
Among patients diagnosed of breast cancer, of which 
a sample of 36 patients was selected with convenient 
method. Through assigned randomly, 12 patients were 
selected for the MCT group and 12 patients for the MBCT 
group, and the other were assigned control group. 
Inclusion criteria for this study included: Informed 
consent and desire to participate in the study, ability to 
participate in meetings and collaborate on homework, 
diagnosis of breast cancer and age range of 30-55 years, 
minimum education level of high school and a month 
history of cancer (minimum).
Exclusion criteria for experimental group included: 
absence, unwillingness or inability to participate in 
meetings; receiving other treatment. 
The target society of the research included every cancer 
patient who admitted Oncology of Imam Hossein hospital 
in Tehran. Two clinical psychologists did interventions 
also they knew about MBCT and MCT. Thirty-six 
patients were selected with convenient method. MBCT 
intervention included 8 sessions (1 session per week 
about 2 hours).26 The MBCT protocol is presented in 
Table 1. The MCT protocol is presented in Table 2. The 
data collection tools included depression, anxiety and 
stress scale - 21 items (DASS-21) questionnaire. 
Sample Demographic Sheet
The sample sheet included age, sex, educational level, 
and marital status of the patients. It was prepared and 
evaluated by the researchers.
DASS-21
The short form of this questionnaire with 42 questions has 
been examined by Leviband (1995) to assess depression, 
anxiety, and stress.27 Confirmatory factor analysis results 
has confirmed the existence of the 3 factors of depression, 
anxiety and stress. Retest coefficient of 3 subscales of this 
questionnaire was mentioned with sample consisted of 
Table 2. Protocol of MCT Training Sessions
Session Subject 
1st 
 Introducing about this intervention/ identifying rumination periods (metacognition enhancement)/discussing about completing attention training 
technique (ATT) (ATT)/ practicing techniques of increasing attention/ giving homework for next session
2nd Discussing homework, identifying rumination belief and thoughts/introducing and practicing detached mindfulness (DM)/ re- practicing ATT
3rd Examining homework/ examining uncontrollable belief/ discussing about with uncontrollable metacognitions/giving homework for next session
4th Re-examining uncontrollable belief /challenging with positive beliefs about rumination/ practicing ATT/ using DM and postponing the rumination.
5th Re-examining the uncontrollable belief and re- challenging positive belief
6th Identifying negative beliefs and discussing with negative beliefs
7th Examining negative beliefs and useless strategies/writing new designs of recurrent fears
8th Reviewing about all sessions, examining the other cognitive beliefs/discussing about using new program.
Table 1. Protocol of MBCT Training Sessions
Session Subject 
1st 
Introduction about automatic guidance system/knowledge on how to use present moment awareness of bodily sensation, thoughts and emotions 
to reduce stress, give assignment for next week and distributing first CDs about meditation
2nd Examining of body workouts/ giving feedback and discussing body workout/ practicing breathing in mindfulness meditation
3rd Sitting meditation with awareness of breathing/distributing video tape about yoga practices
4th Seeing or hearing practice/ re-practicing sitting meditation 
5th Re- practicing breathing and sitting meditation/ identifying participants’ reactions to stress
6th Practicing knowing about sounds and thoughts
7th Practicing mountain meditation/ writing about a list of enjoyable activities
8th Examining body workout /reviewing and discussing programs 
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20 patients between 71%-81% at an interval of 2 weeks.28 
Reliability and validity of this questionnaire were studied 
on a number of subjects in England.29 Retest reliability for 
depression, anxiety and stress are reported respectively 
80%, 76% and 77% and Cronbach’s alpha for them are 
reported respectively 81%, 79% and 78%. Validity of this 
scale was examined by confirmatory factor analysis and in 
main components method. Kaiser-Meyer-Olkin (KMO) 
index value was equal to 90% and in Bartlett’s test, χ2 
index was equal to 3092.93 that was significant in the 
level of 0.0007 and it suggested adequacy of sample and 
selected variables for factor analysis.
Results
People were ranged from 38 to 49 years. Table 3 shows the 
mean and standard deviation in for age of patients.
Mean and standard deviation of anxiety, depression and 
stress in 3 groups are reported in Table 4.
Results of Table 4 show that the components of 
depression, anxiety and stress are almost similar between 
2 groups. Comparison of the 2 experimental groups in 
post-test and follow-up indicates that mindfulness therapy 
Table 3. Mean and Standard Deviation of Patients
Group Mean SD
Age Control 44.08 3.28
Stress reduction 43.25 3.08
Metacognitive 44.92 1.83
Age at diagnosis time Control 43.33 3.65
Stress reduction 42.25 3.39
Metacognitive 43.75 1.71
Table 4. Mean and Standard Deviation of Anxiety, Depression, Stress in Patients
Control (n = 12) MCT Group (n = 12) MBCT Group (n = 12)
Pre-test Post-test Follow-up Pre-test Post-test Follow-up Pre-test Post-test Follow-Up
Anxiety 14.32±1.3 14.33±1.3 15.33±1.3 19.8±1.4 17.75±1.3 19.50±1.3 12.33±1.4 11.83±1.4 16.8±1.7
Depression 25.08±1.1 21±1.4 21.16±1.58 25.08±1.1 19.50±1.5 22.16±1.1 25.08±0.9 14.91 ±1.9 17.33±2.8
Stress 23.58±0.9 23.91±0.9 24.25±0.6 19.08±1.4 19.41±0.9 24.75±1.4 17.91±2.6 16.25±1.7 25.33±2.1
Table 5. Paired Comparison of Depression, Anxiety and Stress Between 2 Groups
Treatment Treatment Average Difference Standard Deviation P Value
Depression
Mindfulness Metacognition - 3.13 0.455 0.0001
Mindfulness Control - 3.30 0.455 0.0001
Metacognition Control - 0.167 0.450 1
Anxiety
Mindfulness Metacognition - 5.36 0.450 0.0001
Mindfulness Control -1.25 0.450 0.027
Metacognition Control 4.11 0.450 0.0001
Stress
Mindfulness Metacognition -1.58 0.417 0.002
Mindfulness Control - 4.08 0.417 0.0001
Metacognition Control - 2.50 0.417 0.0001
shows more decrease in the mean score of participants in 
depression, anxiety and stress components compared to 
metacognitive therapy.
Multivariate repeated measures model was used to 
compare 2 therapeutic approaches in control group to 
decrease depression, anxiety and stress. Therefore, firstly 
the assumptions of using the model were examined. The 
results of Mauchly’s sphericity test show that the Mauchly’s 
sphericity assumption is rejected in all dimensions but 
anxiety dimension. Thus, Hevin-Felt corrected values were 
used for comparison. The assumption of homogeneity of 
variances was assessed using Levene’s test. The results 
indicate that this assumption is established.
Results of multivariate analysis showed that the time 
factor effect (pre-test, post-test and follow-up) was 
significant (Pillai’s Trace = 0.946, F28, 6 = 81.15, P < 0.0001, 
partial eta square = 0.946). Also, time factor interaction 
effect × group was significant (Pillai’s Trace = 1.553, F58, 
12 = 16.80, P < 0.0001, partial eta square = 0.777). Group 
factor effect (control, mindfulness therapy, metacognitive 
therapy) was also significant (Pillai’s Trace = 1.651, F6, 
64 = 50.41, P < 0.0001, partial eta square = 0.825). Results 
of comparison of intergroup effect show that there is a 
significant difference between experimental and control 
groups in depression (F2, 33 = 33.479, P < 0.0001, partial 
eta square = 0.670), anxiety (F2, 33 = 77.69, P < 0.0001, 
partial eta square = 0.825) and stress components (F2, 
33 = 48.80, P < 0.0001, partial eta square = 0.747). To 
examine the interaction effect after experience tests 
with Bonferroni’s adjustment was used. The results are 
presented in Table 5.
Results of paired comparison in Table 5 show that there 
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is a significant difference between mindfulness therapy 
and metacognitive therapy in depression component in 2 
experimental groups. Comparison of means indicate that 
mindfulness therapy is more effective. The comparison 
of experimental and control groups showed that there 
is a significant difference between experimental group 
receiving mindfulness therapy and control group 
in depression component in terms of the amount of 
depression but the difference between experimental 
group receiving metacognitive therapy and control 
group was not significant. The results are presented 
in Table 1. Comparison of mindfulness therapy and 
metacognitive therapy showed that there is a significant 
difference between 2 groups in anxiety component and 
comparison of means showed mindfulness therapy is 
more effective. Comparison of each experimental group 
with control group showed the effectiveness of both 
therapies and decrease in anxiety in experimental groups 
compared to control group. The results are presented 
in Table 2. Comparison of 2 experimental groups in 
terms of the amount of stress indicated that there is 
a significant difference between mindfulness-based 
therapy and metacognitive therapy and the comparison 
of these 2 groups to control group also indicated there is 
a significant difference between experimental groups and 
control group.
Discussion
Studies have shown that we will have 15 million cancer 
patients worldwide by 2020.30 Considering problems 
of breast cancer and its interventions, it seems that it is 
an important factor that we should focus on quality of 
patient’s life.31
As the results show, anxiety, depression and stress scores 
decrease in experimental groups in variables and then 
people showed stability in follow-up. MBCT have shown 
effectiveness on variables in participates than MCT. This 
finding is consistent with results of studies conducted in 
Iran and the world.32
Studies showed reductions in research variables after 
treatments and our results show consistent with these 
studies.21,27 In addition, MBCT intervention showed more 
impact in experimental group. However, positive impact 
of treatment was not continued in follow-up. In this regard 
findings have been similar with previous studies.18,33
While application of MBCT intervention has reduced 
side effect significantly and increased quality of life 
and well-being in the control group and MCT group. 
Therefore, several studies have supported the impact of 
MBCT on anxiety.18, 21 Carlson and Spaca have investigated 
not only impact of MBCT in declining anxiety, pressure 
and physical stress, but also enchanting mental health, 
quality of life and well-being.21 Research investigated 
conscious practices and levels, medical and psychological 
symptoms have an important roles and effect in MBCT 
intervention.34
Furthermore, knowledge and understanding of 
mindfulness by meditation practices through MBCT 
can help increase in self-awareness and self-acceptance 
ability in patients. Therefore, MBCT is an accessible 
pattern to decrease pain and growth of positive quality 
of life; consequently, this dynamic growth improves 
the management of depression, anxiety and stress.17 
Consistent with the present findings, MBCT by using self-
regulation has a valuable impact on experience patients 
and this treatment help cancer people to become relax 
and awareness.34 
Based on the results of the present study, the MCT 
program has a role in identifying rumination periods, 
core belief and intermediate beliefs. In addition, this 
intervention uses practical techniques in order to increase 
attention. MCT program try to identify the rumination 
belief and uncontrollable thoughts, in addition to modify 
uncontrollable beliefs and preventing harmful coping 
behavior. MCT follows cognitive method. 
There were some limitations for the study including 
small sample size per group and also since some patient 
were not willing to participate in the study affects the 
generalization of the findings to the population of the 
study. Therefore, it is suggested to promote the patients 
to participate in training and psychotherapy sessions by 
emphasizing the importance of mental health along with 
medical treatments. This study was done on patients of 
Imam Hossein hospital in Tehran. Therefore, researchers 
recommend that similar studies should be performed on 
specific types of cancer in samples selected from different 
cities.
Conflict of Interest Disclosures 




1. Rahmani S, Talepasand S. The effect of group mindfulness - 
based stress reduction program and conscious yoga on the 
fatigue severity and global and specific life quality in women 
with breast cancer. Med J Islam Repub Iran. 2015;29:175. 
2. Chen PY, Chang HC. The coping process of patients with 
cancer. Eur J Oncol Nurs. 2012;16(1):10-6. doi: 10.1016/j.
ejon.2011.01.002.
3. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, 
Oberaigner W, et al. European health systems and cancer 
care. Ann Oncol. 2003;14 Suppl 5:v41-60.
4. Hopko DR, Bell JL, Armento M, Robertson S, Mullane C, Wolf 
N, et al. Cognitive-behavior therapy for depressed cancer 
patients in a medical care setting. Behav Ther. 2008;39(2):126-
36. doi: 10.1016/j.beth.2007.05.007.
5. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby 
JM, Lau MA. Prevention of relapse/recurrence in major 
depression by mindfulness-based cognitive therapy. J Consult 
Clin Psychol. 2000;68(4):615-23.
6. Daughters SB, Braun AR, Sargeant MN, Reynolds EK, Hopko 
DR, Blanco C, et al. Effectiveness of a brief behavioral 
treatment for inner-city illicit drug users with elevated 
Haji Seyed Javadi et al
Int Clin Neurosci J. Vol 5, No 2, Spring 201866 journals.sbmu.ac.ir/Neurosciencehttp
depressive symptoms: the life enhancement treatment for 
substance use (LETS Act!). J Clin Psychiatry. 2008;69(1):122-
9. 
7. Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner 
K, Gollan JK, et al. A component analysis of cognitive-
behavioral treatment for depression. J Consult Clin Psychol. 
1996;64(2):295-304. 
8. Roelofs J, Huibers M, Peeters F, Arntz A, van Os J. Rumination 
and worrying as possible mediators in the relation between 
neuroticism and symptoms of depression and anxiety 
in clinically depressed individuals. Behav Res Ther. 
2008;46(12):1283-9. doi: 10.1016/j.brat.2008.10.002.
9. Fisher PL, Wells A. Metacognitive therapy for obsessive-
compulsive disorder: a case series. J Behav Ther Exp Psychiatry. 
2008;39(2):117-32. doi: 10.1016/j.jbtep.2006.12.001.
10. Williams JM, Duggan DS, Crane C, Fennell MJ. Mindfulness-
based cognitive therapy for prevention of recurrence of 
suicidal behavior. J Clin Psychol. 2006;62(2):201-10. doi: 
10.1002/jclp.20223.
11. Wells A. Metacognitive therapy for anxiety and depression. 
New York: Guilford Press; 2015.
12. Osborn RL, Demoncada AC, Feuerstein M. Psychosocial 
interventions for depression, anxiety, and quality of life 
in cancer survivors: meta-analyses. Int J Psychiatry Med. 
2006;36(1):13-34. doi: 10.2190/eufn-rv1k-y3tr-fk0l.
13. Kabat-Zinn J. Mindfulness-Based Interventions in Context: 
Past, Present, and Future. Clinical Psychology: Science and 
Practice. 2003;10(2):144-56. doi: 10.1093/clipsy.bpg016.
14. Kabat-Zinn J. Coming to our senses: Healing ourselves and 
the world through Mindfulness. New York: Hyperion; 2015.
15. Matousek RH, Dobkin PL, Pruessner J. Cortisol as a marker 
for improvement in mindfulness-based stress reduction. 
Complement Ther Clin Pract. 2010;16(1):13-9. doi: 10.1016/j.
ctcp.2009.06.004.
16. Brantley J. Mindfulness-based cognitive therapy. In: Orsillo 
SM, Roemer L, eds. Acceptance and mindfulness-based 
approaches to anxiety: Conceptualization and treatment. 
New York: Springer; 2015:131-45. 
17. Baer R. Mindfulness-based treatment approaches: Clinician’s 
guide to evidence base and applications. San Diego: Elsevier; 
2012. 
18. Speca M, Carlson LE, Goodey E, Angen M. A randomized, 
wait-list controlled clinical trial: the effect of a mindfulness 
meditation-based stress reduction program on mood and 
symptoms of stress in cancer outpatients. Psychosom Med. 
2000;62(5):613-22.
19. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based 
stress reduction in relation to quality of life, mood, symptoms 
of stress, and immune parameters in breast and prostate 
cancer outpatients. Psychosom Med. 2003;65(4):571-81.
20. Carlson L, Specs M. Mindfulness-Based Cancer Recovery: 
A Step-by-Step MBSR Approach to Help You Cope with 
Treatment and Reclaim Your Life. Oakland, CA: New 
Harbinger; 2011:17-31.
21. Zeichner RL, Kibler JL, Zeichner SB. Relationship between 
Mindfulness-based cognitive therapy and Immune Function 
in Cancer and HIV/AIDS. Cancer Clin Oncol. 2013;2(1):62-
72.
22. Hasanvandi S, Valizadeh M, Mehrabizadeh M. Effect of 
group metacognitive therapy on depression symptom and 
rumination. Journal of Fundamentals of Mental Health. 
2013;15(57):432-42.
23. Wells A, Welford M, Fraser J, King P, Mendel E, Wisely J, et al. 
Chronic PTSD Treated With Metacognitive Therapy: An Open 
Trial. Cogn Behav Pract. 2008;15(1):85-92. doi: 10.1016/j.
cbpra.2006.11.005.
24. Wells A, Sembi S. Metacognitive therapy for PTSD: a 
preliminary investigation of a new brief treatment. J Behav 
Ther Exp Psychiatry. 2004;35(4):307-18. doi: 10.1016/j.
jbtep.2004.07.001.
25. Wells A, Papageorgiou C. Brief cognitive therapy for social 
phobia: a case series. Behav Res Ther. 2001;39(6):713-20.
26. Chaskalon M. The mindful workplace: developing resilient 
individuals and resonant organizations with MBSR. Wiley-
Blackwell; 2011:230-2.
27. Lovibond PF, Lovibond SH. The structure of negative 
emotional states: comparison of the Depression Anxiety 
Stress Scales (DASS) with the Beck Depression and Anxiety 
Inventories. Behav Res Ther. 1995;33(3):335-43.
28. Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinton RP. 
Psychometric properties of the 42-item and 21-item versions 
of the Depression Anxiety Stress Scales in clinical groups and 
a community sample. Psychol Assess.1998;10(2):176-81. doi: 
10.1037/1040-3590.10.2.176.
29. Samani S, Jokar B. A study on the reliability and validity of 
the short form of the depression anxiety stress scale (DASS-
21). Journal of Social Sciences and Humanities of Shiraz 
University. 2007;26(3):65-75. (Persian).
30. Rahmani S, Talepasand S, Ghanbary-Motlagh A. Comparison 
of effectiveness of the metacognition treatment and the 
mindfulness-based stress reduction treatment on global 
and specific life quality of women with breast cancer. Iran J 
Cancer Prev. 2014;7(4):184-96.
31. Talepasand S, Pooragha F, Kazemi M. Resiliency and quality 
of life in patients with cancer: moderating role of duration 
of awareness of cancer. Iran J Cancer Prev. 2013;6(4):222-6.
32. Meeker MA, Finnell D, Othman AK. Family caregivers 
and cancer pain management: a review. J Fam Nurs. 
2011;17(1):29-60. doi: 10.1177/1074840710396091.
33. Lengacher CA, Johnson-Mallard V, Barta M, Fitzgerald S, 
Moscoso MS, Post-White J, et al. Feasibility of a mindfulness-
based stress reduction program for early-stage breast 
cancer survivors. J Holist Nurs. 2011;29(2):107-17. doi: 
10.1177/0898010110385938.
34. Carmody J, Baer RA. Relationships between mindfulness 
practice and levels of mindfulness, medical and psychological 
symptoms and well-being in a mindfulness-based stress 
reduction program. J Behav Med. 2008;31(1):23-33. doi: 
10.1007/s10865-007-9130-7.
